How to Commercialise an Advanced Therapy: Lessons Learned and Future Plans

Advanced therapy clinical trials are growing, with a record number of therapies being approved in 2021. This increase in approvals has led many to predict that the commercialization of advanced therapies is not far away

It offers the potential for fantastic breakthroughs for patients. But it’s vitally important that the supply chain is fully equipped to deal with this new reality. Pharmaceutical companies, suppliers, and manufacturers need to start preparing themselves for this demand right away, with storage facilities being a key concern. Failure to get ahead of the issue will increase cost and time pressures further down the line.

Join our panel of experts to as they discuss why the time is now and why it pays to be prepared for the commercialization of advanced therapies.

Did you enjoy this session? If so, you might like to visit our Connect to Frankfurt platform, where you can browse our collection of 30+ on-demand webinars and learn about our upcoming CPHI Frankfurt event, taking place 1-3 November in Frankfurt, Germany.

Bringing together the global supply chain under one roof, CPHI Frankfurt puts you at the heart of pharma. Can’t attend in person? You can access many of the event offerings online! Browse our exhibitor list, arrange meetings, view on-site content and network – all from home.

Click here to register